SPECTRE Special Pathogens Excellence in Clinical Treatment Readiness & Education Program

Welcome to SPECTRE!

We are SPECTRE—the Special Pathogens Excellence in Clinical Treatment, Readiness, and Education Program—housed within the Division of Infectious Diseases at UTMB. Our mission is to strengthen local and regional readiness to respond to high-consequence infectious diseases, ensuring self-sufficiency and operational resilience.

SPECTRE supports the ongoing preparedness of UTMB’s Biocontainment Care Unit (BCU) by developing targeted training and education initiatives grounded in practical, frontline care. We focus on equipping healthcare professionals, across all of Region 6, with the skills, tools, and confidence needed to act swiftly and safely during special pathogen events.

We also foster collaboration with regional healthcare partners and public health entities, promoting a unified, state-driven response framework that ensures coordination without unnecessary duplication of federal efforts. In addition, we contribute to the infrastructure needed for clinically grounded research, ensuring that emerging knowledge translates directly into improved patient care and safety protocols.

 

Trending Topics

Who is SPECTRE

SPECTRE strengthens healthcare preparedness through training, education, research, and regional coordination. By equipping healthcare professionals with specialized skills, advancing infectious disease research, and leading regional preparedness efforts, SPECTRE enhances the ability to manage high-consequence infectious diseases. This video highlights SPECTRE’s mission and its role in providing healthcare professionals with the knowledge and resources needed to respond effectively. Through evidence-based education, research, and strategic partnerships, SPECTRE helps build stronger response capabilities at institutional, regional, and national levels.

What we do

News & Events

 Latest News

Poll: 83% of Americans say benefits of MMR vaccines outweigh risks

A recent Annenberg Poll shows strong public backing for the MMR vaccine, even as measles cases climb across the U.S. and Canada. However, the findings also reveal significant gaps in awareness about the disease and continued belief in ineffective treatments.

  • 87% support MMR vaccine benefits; 80% favor school-entry mandates.

  • Many remain uncertain about measles risks, especially in pregnancy.

  • Public is divided on unproven treatments like vitamin A and cod liver oil.

Read more